Clarient

Acquired

Home | NeoGenomics Laboratories

Founded 2003 · $29.1M raised

Employees
201–500
Founded
2003
Business Model
B2B
Total Funding
$29.1M
Last Round
$29.1M Venture RoundMar 2009
Rounds
1
Acquisition Date
Oct 2010

About

Clarient provided comprehensive cancer diagnostic testing to hospitals, physicians, and the pharmaceutical industry as a unit of GE Healthcare's Life Sciences business. The company operated laboratories in Aliso Viejo, California and Houston, Texas, offering advanced oncology diagnostics used to inform cancer treatment decisions. NeoGenomics completed its acquisition of Clarient and Clarient Diagnostic Services in December 2015; clarientinc.com now serves NeoGenomics Laboratories precision oncology testing pages.

Summary

Clarient is a Biotech company, founded in 2003. It has raised $29.1M in total across 1 round, most recently a $29.1M Venture Round round in Mar 2009. Investors include GE Healthcare and Oak Investment Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionAcquisition by GE HealthcareOct 2010

Sign up to see all 2 rounds

Venture Round through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Clarient on Indexed.vc
<a href="https://indexed.vc/companies/clarient"><img src="https://indexed.vc/api/badge/company/clarient" alt="Clarient on Indexed.vc" width="260" height="76" /></a>